A Practical Guide to Solving Diagnostic Problems in Breast, Genitourinary , Liver, Gastrointestinal & Pancreatic Biliary Pathology

Question Title

* 1. To what extent were course objectives met to cover (5 being the best and 1 being not at all):

	1	2	3	4	5
Up-to-date criteria for the diagnosis of selected common and less common entities and important, recently reported tumor variants.	Up-to-date criteria for the diagnosis of selected common and less common entities and important, recently reported tumor variants. 1	Up-to-date criteria for the diagnosis of selected common and less common entities and important, recently reported tumor variants. 2	Up-to-date criteria for the diagnosis of selected common and less common entities and important, recently reported tumor variants. 3	Up-to-date criteria for the diagnosis of selected common and less common entities and important, recently reported tumor variants. 4	Up-to-date criteria for the diagnosis of selected common and less common entities and important, recently reported tumor variants. 5
Use of appropriate ancillary immunohistochemical studies and molecular genetic assays in the work-up.	Use of appropriate ancillary immunohistochemical studies and molecular genetic assays in the work-up. 1	Use of appropriate ancillary immunohistochemical studies and molecular genetic assays in the work-up. 2	Use of appropriate ancillary immunohistochemical studies and molecular genetic assays in the work-up. 3	Use of appropriate ancillary immunohistochemical studies and molecular genetic assays in the work-up. 4	Use of appropriate ancillary immunohistochemical studies and molecular genetic assays in the work-up. 5
Guidance on dealing with challenging lesions and avoidance of pitfalls contributing to misdiagnosis.	Guidance on dealing with challenging lesions and avoidance of pitfalls contributing to misdiagnosis. 1	Guidance on dealing with challenging lesions and avoidance of pitfalls contributing to misdiagnosis. 2	Guidance on dealing with challenging lesions and avoidance of pitfalls contributing to misdiagnosis. 3	Guidance on dealing with challenging lesions and avoidance of pitfalls contributing to misdiagnosis. 4	Guidance on dealing with challenging lesions and avoidance of pitfalls contributing to misdiagnosis. 5

Question Title

* 2. To what extent were (5 being the completely and 1 being not at all):

	1	2	3	4	5
Course contents up-to-date.	Course contents up-to-date. 1	Course contents up-to-date. 2	Course contents up-to-date. 3	Course contents up-to-date. 4	Course contents up-to-date. 5
Slides and handouts useful to learning.	Slides and handouts useful to learning. 1	Slides and handouts useful to learning. 2	Slides and handouts useful to learning. 3	Slides and handouts useful to learning. 4	Slides and handouts useful to learning. 5
Your questions answered.	Your questions answered. 1	Your questions answered. 2	Your questions answered. 3	Your questions answered. 4	Your questions answered. 5
Your interactions via email with faculty sufficient.	Your interactions via email with faculty sufficient. 1	Your interactions via email with faculty sufficient. 2	Your interactions via email with faculty sufficient. 3	Your interactions via email with faculty sufficient. 4	Your interactions via email with faculty sufficient. 5
Subjects covered useful to your practice.	Subjects covered useful to your practice. 1	Subjects covered useful to your practice. 2	Subjects covered useful to your practice. 3	Subjects covered useful to your practice. 4	Subjects covered useful to your practice. 5
Online Experience Satisfactory	Online Experience Satisfactory 1	Online Experience Satisfactory 2	Online Experience Satisfactory 3	Online Experience Satisfactory 4	Online Experience Satisfactory 5

Question Title

* 3. 2/1/2021 Please rate the following presentations (5 being the best and 1 being not at all):

	1	2	3	4	5
7:30am Correlation, Concordance and other Considerations for Core Biopsy (Laura Collins, M.D.)	7:30am Correlation, Concordance and other Considerations for Core Biopsy (Laura Collins, M.D.) 1	7:30am Correlation, Concordance and other Considerations for Core Biopsy (Laura Collins, M.D.) 2	7:30am Correlation, Concordance and other Considerations for Core Biopsy (Laura Collins, M.D.) 3	7:30am Correlation, Concordance and other Considerations for Core Biopsy (Laura Collins, M.D.) 4	7:30am Correlation, Concordance and other Considerations for Core Biopsy (Laura Collins, M.D.) 5
8:30am Diagnostic Dilemmas in Ductal Proliferations (Laura Collins, M.D.)	8:30am Diagnostic Dilemmas in Ductal Proliferations (Laura Collins, M.D.) 1	8:30am Diagnostic Dilemmas in Ductal Proliferations (Laura Collins, M.D.) 2	8:30am Diagnostic Dilemmas in Ductal Proliferations (Laura Collins, M.D.) 3	8:30am Diagnostic Dilemmas in Ductal Proliferations (Laura Collins, M.D.) 4	8:30am Diagnostic Dilemmas in Ductal Proliferations (Laura Collins, M.D.) 5
9:30am Pancreatic Ductal Adenocarcinoma and Its Variants in the Neoadjuvant Era (Aatur Singhi)	9:30am Pancreatic Ductal Adenocarcinoma and Its Variants in the Neoadjuvant Era (Aatur Singhi) 1	9:30am Pancreatic Ductal Adenocarcinoma and Its Variants in the Neoadjuvant Era (Aatur Singhi) 2	9:30am Pancreatic Ductal Adenocarcinoma and Its Variants in the Neoadjuvant Era (Aatur Singhi) 3	9:30am Pancreatic Ductal Adenocarcinoma and Its Variants in the Neoadjuvant Era (Aatur Singhi) 4	9:30am Pancreatic Ductal Adenocarcinoma and Its Variants in the Neoadjuvant Era (Aatur Singhi) 5
11:00am Interpretation of Reactive and Dysplastic Changes in Barrett's Esophagus (Lisa Yerian, M.D.)	11:00am Interpretation of Reactive and Dysplastic Changes in Barrett's Esophagus (Lisa Yerian, M.D.) 1	11:00am Interpretation of Reactive and Dysplastic Changes in Barrett's Esophagus (Lisa Yerian, M.D.) 2	11:00am Interpretation of Reactive and Dysplastic Changes in Barrett's Esophagus (Lisa Yerian, M.D.) 3	11:00am Interpretation of Reactive and Dysplastic Changes in Barrett's Esophagus (Lisa Yerian, M.D.) 4	11:00am Interpretation of Reactive and Dysplastic Changes in Barrett's Esophagus (Lisa Yerian, M.D.) 5
12:00pm Updates and Approach to the WHO Classification of Adult Renal Neoplasia, including Medullary-Based Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.)	12:00pm Updates and Approach to the WHO Classification of Adult Renal Neoplasia, including Medullary-Based Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 1	12:00pm Updates and Approach to the WHO Classification of Adult Renal Neoplasia, including Medullary-Based Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 2	12:00pm Updates and Approach to the WHO Classification of Adult Renal Neoplasia, including Medullary-Based Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 3	12:00pm Updates and Approach to the WHO Classification of Adult Renal Neoplasia, including Medullary-Based Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 4	12:00pm Updates and Approach to the WHO Classification of Adult Renal Neoplasia, including Medullary-Based Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 5

Question Title

* 4. 2/2/2021 Please rate the following presentations (5 being the best and 1 being not at all):

	1	2	3	4	5	N/A
7:30am The Diagnosis of Cystic and Intraductal Neoplasms of the Pancreas (Aatur Singhi, M.D., Ph.D.)	7:30am The Diagnosis of Cystic and Intraductal Neoplasms of the Pancreas (Aatur Singhi, M.D., Ph.D.) 1	7:30am The Diagnosis of Cystic and Intraductal Neoplasms of the Pancreas (Aatur Singhi, M.D., Ph.D.) 2	7:30am The Diagnosis of Cystic and Intraductal Neoplasms of the Pancreas (Aatur Singhi, M.D., Ph.D.) 3	7:30am The Diagnosis of Cystic and Intraductal Neoplasms of the Pancreas (Aatur Singhi, M.D., Ph.D.) 4	7:30am The Diagnosis of Cystic and Intraductal Neoplasms of the Pancreas (Aatur Singhi, M.D., Ph.D.) 5	7:30am The Diagnosis of Cystic and Intraductal Neoplasms of the Pancreas (Aatur Singhi, M.D., Ph.D.) N/A
8:30am Making Sense of Nomenclature, WHO Grading and Staging of Pancreatic Neuroendocrine Neoplasms (Aatur Singhi, M.D., Ph.D.)	8:30am Making Sense of Nomenclature, WHO Grading and Staging of Pancreatic Neuroendocrine Neoplasms (Aatur Singhi, M.D., Ph.D.) 1	8:30am Making Sense of Nomenclature, WHO Grading and Staging of Pancreatic Neuroendocrine Neoplasms (Aatur Singhi, M.D., Ph.D.) 2	8:30am Making Sense of Nomenclature, WHO Grading and Staging of Pancreatic Neuroendocrine Neoplasms (Aatur Singhi, M.D., Ph.D.) 3	8:30am Making Sense of Nomenclature, WHO Grading and Staging of Pancreatic Neuroendocrine Neoplasms (Aatur Singhi, M.D., Ph.D.) 4	8:30am Making Sense of Nomenclature, WHO Grading and Staging of Pancreatic Neuroendocrine Neoplasms (Aatur Singhi, M.D., Ph.D.) 5	8:30am Making Sense of Nomenclature, WHO Grading and Staging of Pancreatic Neuroendocrine Neoplasms (Aatur Singhi, M.D., Ph.D.) N/A
9:30am Overview of Nonneoplastic Gastric Pathology (Lisa Yerian, M.D.)	9:30am Overview of Nonneoplastic Gastric Pathology (Lisa Yerian, M.D.) 1	9:30am Overview of Nonneoplastic Gastric Pathology (Lisa Yerian, M.D.) 2	9:30am Overview of Nonneoplastic Gastric Pathology (Lisa Yerian, M.D.) 3	9:30am Overview of Nonneoplastic Gastric Pathology (Lisa Yerian, M.D.) 4	9:30am Overview of Nonneoplastic Gastric Pathology (Lisa Yerian, M.D.) 5	9:30am Overview of Nonneoplastic Gastric Pathology (Lisa Yerian, M.D.) N/A
11:00am Updates in Onococytic Adult Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.)	11:00am Updates in Onococytic Adult Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 1	11:00am Updates in Onococytic Adult Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 2	11:00am Updates in Onococytic Adult Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 3	11:00am Updates in Onococytic Adult Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 4	11:00am Updates in Onococytic Adult Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) 5	11:00am Updates in Onococytic Adult Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.) N/A
12:00pm A Lesson on Lobular Lesions (Laura Collins, M.D.)	12:00pm A Lesson on Lobular Lesions (Laura Collins, M.D.) 1	12:00pm A Lesson on Lobular Lesions (Laura Collins, M.D.) 2	12:00pm A Lesson on Lobular Lesions (Laura Collins, M.D.) 3	12:00pm A Lesson on Lobular Lesions (Laura Collins, M.D.) 4	12:00pm A Lesson on Lobular Lesions (Laura Collins, M.D.) 5	12:00pm A Lesson on Lobular Lesions (Laura Collins, M.D.) N/A

Question Title

* 5. 2/3/2021 Please rate the following presentations (5 being the best and 1 being not at all):

	1	2	3	4	5	N/A
7:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 1 (Lisa Yerian, M.D.)	7:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 1 (Lisa Yerian, M.D.) 1	7:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 1 (Lisa Yerian, M.D.) 2	7:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 1 (Lisa Yerian, M.D.) 3	7:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 1 (Lisa Yerian, M.D.) 4	7:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 1 (Lisa Yerian, M.D.) 5	7:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 1 (Lisa Yerian, M.D.) N/A
8:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 2 (Lisa Yerian, M.D.)	8:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 2 (Lisa Yerian, M.D.) 1	8:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 2 (Lisa Yerian, M.D.) 2	8:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 2 (Lisa Yerian, M.D.) 3	8:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 2 (Lisa Yerian, M.D.) 4	8:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 2 (Lisa Yerian, M.D.) 5	8:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 2 (Lisa Yerian, M.D.) N/A
9:30am A Contemporary Approach to Prostatic Adenocarcinoma, Including Poor Prognostic Indicators (Michelle Hirsch, M.D., Ph.D.)	9:30am A Contemporary Approach to Prostatic Adenocarcinoma, Including Poor Prognostic Indicators (Michelle Hirsch, M.D., Ph.D.) 1	9:30am A Contemporary Approach to Prostatic Adenocarcinoma, Including Poor Prognostic Indicators (Michelle Hirsch, M.D., Ph.D.) 2	9:30am A Contemporary Approach to Prostatic Adenocarcinoma, Including Poor Prognostic Indicators (Michelle Hirsch, M.D., Ph.D.) 3	9:30am A Contemporary Approach to Prostatic Adenocarcinoma, Including Poor Prognostic Indicators (Michelle Hirsch, M.D., Ph.D.) 4	9:30am A Contemporary Approach to Prostatic Adenocarcinoma, Including Poor Prognostic Indicators (Michelle Hirsch, M.D., Ph.D.) 5	9:30am A Contemporary Approach to Prostatic Adenocarcinoma, Including Poor Prognostic Indicators (Michelle Hirsch, M.D., Ph.D.) N/A
11:00am Pesky Papillary Lesions (Laura Collins, M.D.)	11:00am Pesky Papillary Lesions (Laura Collins, M.D.) 1	11:00am Pesky Papillary Lesions (Laura Collins, M.D.) 2	11:00am Pesky Papillary Lesions (Laura Collins, M.D.) 3	11:00am Pesky Papillary Lesions (Laura Collins, M.D.) 4	11:00am Pesky Papillary Lesions (Laura Collins, M.D.) 5	11:00am Pesky Papillary Lesions (Laura Collins, M.D.) N/A
12:00pm The Challenges of Gallbladder and Biliary Pathology (Aatur Singhi, M.D., Ph.D.)	12:00pm The Challenges of Gallbladder and Biliary Pathology (Aatur Singhi, M.D., Ph.D.) 1	12:00pm The Challenges of Gallbladder and Biliary Pathology (Aatur Singhi, M.D., Ph.D.) 2	12:00pm The Challenges of Gallbladder and Biliary Pathology (Aatur Singhi, M.D., Ph.D.) 3	12:00pm The Challenges of Gallbladder and Biliary Pathology (Aatur Singhi, M.D., Ph.D.) 4	12:00pm The Challenges of Gallbladder and Biliary Pathology (Aatur Singhi, M.D., Ph.D.) 5	12:00pm The Challenges of Gallbladder and Biliary Pathology (Aatur Singhi, M.D., Ph.D.) N/A

Question Title

* 6. 2/4/2021 Please rate the following presentations (5 being the best and 1 being not at all):

	1	2	3	4	5	N/A
7:30am Having Fun with Testicular Tumors (Michelle Hirsch, M.D., Ph.D.)	7:30am Having Fun with Testicular Tumors (Michelle Hirsch, M.D., Ph.D.) 1	7:30am Having Fun with Testicular Tumors (Michelle Hirsch, M.D., Ph.D.) 2	7:30am Having Fun with Testicular Tumors (Michelle Hirsch, M.D., Ph.D.) 3	7:30am Having Fun with Testicular Tumors (Michelle Hirsch, M.D., Ph.D.) 4	7:30am Having Fun with Testicular Tumors (Michelle Hirsch, M.D., Ph.D.) 5	7:30am Having Fun with Testicular Tumors (Michelle Hirsch, M.D., Ph.D.) N/A
8:30am Practical Points and Biomarkers in GU Pathology (Michelle Hirsch, M.D., Ph.D.)	8:30am Practical Points and Biomarkers in GU Pathology (Michelle Hirsch, M.D., Ph.D.) 1	8:30am Practical Points and Biomarkers in GU Pathology (Michelle Hirsch, M.D., Ph.D.) 2	8:30am Practical Points and Biomarkers in GU Pathology (Michelle Hirsch, M.D., Ph.D.) 3	8:30am Practical Points and Biomarkers in GU Pathology (Michelle Hirsch, M.D., Ph.D.) 4	8:30am Practical Points and Biomarkers in GU Pathology (Michelle Hirsch, M.D., Ph.D.) 5	8:30am Practical Points and Biomarkers in GU Pathology (Michelle Hirsch, M.D., Ph.D.) N/A
9:30am Unique and Unusual Breast Lesions (Laura Collins, M.D.)	9:30am Unique and Unusual Breast Lesions (Laura Collins, M.D.) 1	9:30am Unique and Unusual Breast Lesions (Laura Collins, M.D.) 2	9:30am Unique and Unusual Breast Lesions (Laura Collins, M.D.) 3	9:30am Unique and Unusual Breast Lesions (Laura Collins, M.D.) 4	9:30am Unique and Unusual Breast Lesions (Laura Collins, M.D.) 5	9:30am Unique and Unusual Breast Lesions (Laura Collins, M.D.) N/A
11:00am Pancreatobiliary Frozen Section Nightmares (Aatur Singhi, M.D., Ph.D.)	11:00am Pancreatobiliary Frozen Section Nightmares (Aatur Singhi, M.D., Ph.D.) 1	11:00am Pancreatobiliary Frozen Section Nightmares (Aatur Singhi, M.D., Ph.D.) 2	11:00am Pancreatobiliary Frozen Section Nightmares (Aatur Singhi, M.D., Ph.D.) 3	11:00am Pancreatobiliary Frozen Section Nightmares (Aatur Singhi, M.D., Ph.D.) 4	11:00am Pancreatobiliary Frozen Section Nightmares (Aatur Singhi, M.D., Ph.D.) 5	11:00am Pancreatobiliary Frozen Section Nightmares (Aatur Singhi, M.D., Ph.D.) N/A
12:00pm Liver Transplant Pathology (Lisa Yerian, M.D.)	12:00pm Liver Transplant Pathology (Lisa Yerian, M.D.) 1	12:00pm Liver Transplant Pathology (Lisa Yerian, M.D.) 2	12:00pm Liver Transplant Pathology (Lisa Yerian, M.D.) 3	12:00pm Liver Transplant Pathology (Lisa Yerian, M.D.) 4	12:00pm Liver Transplant Pathology (Lisa Yerian, M.D.) 5	12:00pm Liver Transplant Pathology (Lisa Yerian, M.D.) N/A

Question Title

* 7. Did you email the speakers during you had during their lectures? If so, were your questions answered? If you did not email them, why?

Question Title

* 8. Specialty (please check one):

Surgical Pathologist

Clinical Pathologist

Dermatopathologist

Pathology Resident

Pathology Fellow

Cytopathologist

Pathologist Assist.

Question Title

* 9. Years in practice:

Question Title

* 10. How did you learn about this program? (Please check one)

Email Blast

Internet Search

Word of mouth

Pathology Outlines.com

SSI Website

Previous attendee

Other (please specify)

Question Title

* 11. What Factors Influenced You to Attend this Online Course? Please rate the
order of importance how the following factors influenced your decision to attend this course from 6 (Most) to 1 (Least):

	1	2	3	4	5	6
Location (Online)	Location (Online) 1	Location (Online) 2	Location (Online) 3	Location (Online) 4	Location (Online) 5	Location (Online) 6
CME Credits	CME Credits 1	CME Credits 2	CME Credits 3	CME Credits 4	CME Credits 5	CME Credits 6
Course Topics	Course Topics 1	Course Topics 2	Course Topics 3	Course Topics 4	Course Topics 5	Course Topics 6
Faculty	Faculty 1	Faculty 2	Faculty 3	Faculty 4	Faculty 5	Faculty 6
Company Reputation	Company Reputation 1	Company Reputation 2	Company Reputation 3	Company Reputation 4	Company Reputation 5	Company Reputation 6
Online Option	Online Option 1	Online Option 2	Online Option 3	Online Option 4	Online Option 5	Online Option 6

Question Title

* 12. Which Season of the Year is Best for You? Please rate from 1 (Best) to 5 (Least):

	1	2	3	4	5	6
Winter	Winter 1	Winter 2	Winter 3	Winter 4	Winter 5	Winter 6
Spring	Spring 1	Spring 2	Spring 3	Spring 4	Spring 5	Spring 6
Summer	Summer 1	Summer 2	Summer 3	Summer 4	Summer 5	Summer 6
Fall	Fall 1	Fall 2	Fall 3	Fall 4	Fall 5	Fall 6
Anytime if Online is available	Anytime if Online is available 1	Anytime if Online is available 2	Anytime if Online is available 3	Anytime if Online is available 4	Anytime if Online is available 5	Anytime if Online is available 6

Question Title

* 13. Please rate each attribute 1 to 5 (5 = Excellent, 1 = Poor):

	1	2	3	4	5
Educational Handouts	Educational Handouts 1	Educational Handouts 2	Educational Handouts 3	Educational Handouts 4	Educational Handouts 5
Level of material presented	Level of material presented 1	Level of material presented 2	Level of material presented 3	Level of material presented 4	Level of material presented 5
Interaction with speakers via Email	Interaction with speakers via Email 1	Interaction with speakers via Email 2	Interaction with speakers via Email 3	Interaction with speakers via Email 4	Interaction with speakers via Email 5
Length of course	Length of course 1	Length of course 2	Length of course 3	Length of course 4	Length of course 5
Convenience	Convenience 1	Convenience 2	Convenience 3	Convenience 4	Convenience 5
Faculty	Faculty 1	Faculty 2	Faculty 3	Faculty 4	Faculty 5
Audio visuals	Audio visuals 1	Audio visuals 2	Audio visuals 3	Audio visuals 4	Audio visuals 5
Course Organization	Course Organization 1	Course Organization 2	Course Organization 3	Course Organization 4	Course Organization 5

Question Title

* 14. Did this course help you identify specific gaps in your knowledge/practice? If so which areas?

Question Title

* 15. Do you feel this course enhanced your professional abilities? If so how?

Question Title

* 16. In which areas in pathology do you feel are in greatest need of CME?

Question Title

* 17. Would You attend More SSI Online Courses?

Yes

No

Question Title

* 18. What did you like/dislike about the Online Experience?